Combining artificial intelligence (AI) with eye tracking in virtual reality could one day help personalise treatment for millions living with chronic pain, according to world-first research from the University of East Anglia.
Eye tracking combined with AI could help future virtual reality therapies adapt to patients’ mental workload, potentially supporting more personalised chronic pain treatment.
Scientists found that tiny changes in pupil size and blinking patterns can reveal how hard the brain is working during virtual reality tasks. The team hope their work could open the door to wearable systems that automatically adapt therapy in real time.
For the millions living with chronic pain, that could represent a significant step towards more personalised, drug-free care.
Lead researcher Dr Jordan Tsigarides, from UEA’s School of Health Sciences, said: “Chronic pain affects an estimated 1.5 billion people worldwide and is one of the leading causes of disability.
“Virtual reality has enormous therapeutic potential - whether that's guiding patients through a peaceful woodland, supporting relaxation exercises or engaging them with games and puzzles that help manage pain.
“It can help reduce chronic pain by immersing users in engaging, interactive environments that capture the brain's attention and draw it away from pain, reduce pain-related stress and anxiety, and may even help retrain how the brain processes pain over time.
“But most virtual reality programmes offer the same experience to everyone, even though people's pain and mental effort can fluctuate from moment to moment.
“Our work suggests future systems could read mental effort through the eyes and adapt therapy in real time to each individual.
“If a headset can detect when someone is becoming mentally overloaded, it could potentially adapt the experience automatically to keep them engaged and maximise therapeutic benefit."
How the Research Happened
The study was led by Dr Jordan Tsigarides as part of his PhD at UEA. “My PhD is exploring how AI and sensor technology could make virtual reality treatments more responsive to the individual. We want to strike the right balance between challenge and comfort,” he said.
The study involved 84 volunteers, including 42 people with chronic musculoskeletal pain conditions such as arthritis and fibromyalgia. Participants completed a series of increasingly demanding memory challenges while wearing a VR headset equipped with eye-tracking technology.
The team discovered that as tasks became more mentally challenging, participants’ pupils widened and their blink rates increased. State-of-the-art AI models that analysed patterns in these signals over time were then able to distinguish between low and high levels of mental workload with up to 88 per cent accuracy in healthy volunteers.
The VR tasks were also well tolerated with participants reporting very low levels of motion sickness and discomfort.
A New Generation of Adaptive VR Treatments
Dr Tsigarides said: “These results suggest a future in which a headset could continuously monitor the brain's workload through the eyes, automatically fine-tuning treatment to each individual user.
“Our earlier research showed promising pain reductions in people with fibromyalgia using therapeutic VR. Now we're exploring how to make those experiences smarter, more responsive, and tailored to each person.
“Until now, most VR has been one-size-fits-all. Our findings could help make treatments more personalised and responsive. This could enhance future VR treatments, not just for pain but potentially for conditions like anxiety or depression.”
“In future, the same principles could be explored in education and professional training, where virtual learning experiences might adapt to the learner’s mental workload.”
However, the study also highlighted a challenge. While AI models performed strongly in healthy volunteers, accuracy was significantly lower among people living with chronic pain, suggesting that standardised approaches may not work equally well for all patients.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
The researchers believe future systems may need to be individually calibrated, learning how each person's eyes respond to mental effort before making treatment decisions.
And they say that larger studies are needed to determine whether adaptive VR therapies can improve real-world outcomes for patients.
Original Article: ‘VR-FOCUS: evaluating eye tracking during a virtual reality N-back task as a marker of cognitive load in chronic pain’; Scientific Reports